FINHUB Insights

TECH · Q1 FY26 · Jul 1 – Sep 30, 2025

Bio-Techne Q1 FY26: where the revenue came from and where it went

Bio-Techne Q1 FY26: revenue $0.29B (−1% year over year). Net profit $0.04B. Largest cohort Consumables $0.23B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jul 1 – Sep 30, 2025
Reported
Nov 5, 2025 10-Q
Sankey diagram of Bio-Techne's income statement for Q1 FY26: revenue of $0.29 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$0.29B −1% year over year
Gross profit$0.19B 66% margin
Operating profit$0.05B 17% margin
Net profit$0.04B 13% margin

The numbers

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Sep 30, 2025).
ItemValueShare of revenueYear over year
Revenue 0.29 100% −1%
Consumables 0.23 81% +0%
Services 0.03 9% +0%
Instruments 0.02 8% −17%
Royalty 0.01 2% +12%
Cost of revenue−0.1034%
Gross profit0.1966% margin+2pp
SG&A−0.1241%−1pp
Other−0.028%+0pp
Operating profit0.0517% margin+3pp
Tax−0.01
Net profit0.0413%+2pp
Filing on EDGAR More quarters of TECH

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.